Response: Re: Pharmacogenomic Variation of CYP2D6 and the Choice of Optimal Adjuvant Endocrine Therapy for Postmenopausal Breast Cancer: A Modeling Analysis
Year: 2008
Type: article
DOI: 10.1093/jnci/djn271
Institutions: Brigham and Women's Hospital, Harvard University, Johns Hopkins University, University of California, Los Angeles, The Lundquist Institute, University of Michigan, Johns Hopkins Medicine, Dana-Farber Cancer Institute, Maine Medical Center, Dana-Farber Brigham Cancer Center, Sidney Kimmel Comprehensive Cancer Center, Harbor–UCLA Medical Center, U-M Rogel Cancer Center, Indiana University School of Medicine
Language: English
Subfield: Pharmacology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2105701723